Skip to main content

Childhood Adenotonsillectomy Does Not Increase Overweight Risk in Adulthood

Medically reviewed by Carmen Pope, BPharm. Last updated on March 26, 2024.

By Lori Solomon HealthDay Reporter

TUESDAY, March 26, 2024 -- Adenotonsillectomy (AT), the primary pediatric obstructive sleep apnea (OSA) treatment, is not associated with an increased risk for being overweight in adulthood, according to a study published online Feb. 28 in the American Journal of Respiratory and Critical Care Medicine.

Aviv D. Goldbart, M.D., from Soroka Medical Center in Beer Sheva, Israel, and colleagues investigated how OSA-indicated AT influences body mass index (BMI) from childhood to adulthood. The analysis included children diagnosed with OSA who underwent either AT (132 individuals) or watchful waiting (WW; 127 individuals) from 1998 to 2000, with follow-up through June 2023.

The researchers found no significant differences in median follow-up BMI between the WW and AT groups (24.7 and 23.6 kg/m2, respectively). For females, median follow-up BMI was higher in both groups than for males (females: 26.9 kg/m2 for WW and 25.7 kg/m2 for AT groups; males: 22.7 and 24.1 kg/m2, respectively). Follow-up BMI was not impacted by baseline median z-score classification. Compared with WW, AT was not significantly associated with a change in adulthood BMI when adjusting for sex, z baseline score, apnea-hypopnea index, socioeconomic status, and pregnancy or childbirth by the end of follow-up.

"While not statistically significant, in the multivariable model, there seems to be a decrease in adulthood BMI among patients undergoing AT compared to WW, which might be attributed to the behavior of patients undergoing AT and their better acceptance of medical recommendations," the authors write.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted March 2024

Read this next

GLP1 Receptor Agonists Do Not Up Risk for Complications After Emergency Surgery

THURSDAY, April 25, 2024 -- The risk for postoperative respiratory complications is similar among patients undergoing emergency surgery regardless of preoperative glucagon-like...

Wearable Technology During Surgery Provides Neurosurgeons With Postural Info

WEDNESDAY, April 24, 2024 -- Wearable technology is feasible to assess postural ergonomics and provide objective biofeedback to neurosurgeons, according to a pilot study published...

Knee Osteoarthritis Symptoms Common After ACL Reconstruction

TUESDAY, April 23, 2024 -- Nearly one-quarter of patients show persistent early knee osteoarthritis (OA) symptoms six to 12 months after anterior cruciate ligament reconstruction...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.